Compounds > 2,2,2',4'-tetrachloroacetophenone
Page last updated: 2024-08-25

2,2,2',4'-tetrachloroacetophenone and Cardiomyopathy, Hypertrophic

2,2,2',4'-tetrachloroacetophenone has been researched along with Cardiomyopathy, Hypertrophic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Alaei, Z; Mahdieh, N; Rabbani, B; Zamani, N1
Lopes, LR1

Other Studies

2 other study(ies) available for 2,2,2',4'-tetrachloroacetophenone and Cardiomyopathy, Hypertrophic

ArticleYear
TCAP gene is not a common cause of cardiomyopathy in Iranian patients.
    European journal of medical research, 2023, Sep-26, Volume: 28, Issue:1

    Topics: Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Female; Humans; Iran; Male

2023
The challenge of assessing variant pathogenicity in candidate Z-disc genes: The example of TCAP in hypertrophic cardiomyopathy.
    Revista portuguesa de cardiologia, 2020, Volume: 39, Issue:6

    Topics: Acetophenones; Cardiomyopathy, Hypertrophic; Connectin; Humans; Mutation; Portugal; Virulence

2020